Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation.

This study explored time-frequency analysis of surface electrocardiograms in patients with persistent atrial fibrillation for monitoring atrial drug action. Drug loading over 3 days with oral flecainide (n = 13) or amiodarone (n = 17) organized the fibrillatory process expressed by decreased atrial fibrillatory rate, increased rate stability, and decreased exponential decay. Effects were more pronounced with flecainide than with amiodarone.

[1]  Martin Stridh,et al.  Echocardiographic and Electrocardiographic Predictors for Atrial Fibrillation Recurrence Following Cardioversion , 2003, Journal of cardiovascular electrophysiology.

[2]  M. Stridh,et al.  Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil. , 1999, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  Akira Fujiki,et al.  Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm. , 2003, The American journal of cardiology.

[4]  Steven Swiryn,et al.  Atrial Fibrillatory Wave Characteristics on Surface Electrogram: , 2004, Journal of cardiovascular electrophysiology.

[5]  David E Haines,et al.  Use of global atrial fibrillation organization to optimize the success of burst pace termination. , 2002, Journal of the American College of Cardiology.

[6]  Leif Sörnmo,et al.  Characterization of atrial fibrillation using the surface ECG: time-dependent spectral properties , 2001, IEEE Transactions on Biomedical Engineering.

[7]  D. Haines,et al.  Assessment of Global Atrial Fibrillation Organization to Optimize Timing of Atrial Defibrillation , 2001, Circulation.

[8]  Martin Stridh,et al.  Frequency Measures Obtained from the Surface Electrocardiogram in Atrial Fibrillation Research and Clinical Decision‐Making , 2003, Journal of cardiovascular electrophysiology.

[9]  Marek Malik,et al.  Optimum lead positioning for recording bipolar atrial electrocardiograms during sinus rhythm and atrial fibrillation , 1998, Clinical cardiology.

[10]  Leif Sörnmo,et al.  Spatiotemporal QRST cancellation techniques for analysis of atrial fibrillation , 2001, IEEE Transactions on Biomedical Engineering.

[11]  M. Allessie,et al.  Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. , 2000, Circulation.

[12]  Akira Fujiki,et al.  Role of fibrillation cycle length in spontaneous and drug-induced termination of human atrial fibrillation. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[13]  D. Todd,et al.  Effect of Amiodarone on Dispersion of Atrial Refractoriness and Cycle Length in Patients with Atrial Fibrillation , 2003, Journal of cardiovascular electrophysiology.

[14]  Andreas Bollmann,et al.  Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide. , 2002, The American journal of cardiology.

[15]  L. Sörnmo,et al.  Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: introducing, validating and illustrating a new ECG method. , 1998, Cardiovascular research.

[16]  Leif Sörnmo,et al.  Sequential characterization of atrial tachyarrhythmias based on ECG time-frequency analysis , 2004, IEEE Transactions on Biomedical Engineering.

[17]  M. Allessie,et al.  High-density mapping of electrically induced atrial fibrillation in humans. , 1994, Circulation.

[18]  J. Langberg,et al.  Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG. , 1999, Cardiovascular research.

[19]  A. Bollmann,et al.  Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide. , 1998, The American journal of cardiology.